Navigation Links
Microban International Announces Breakthrough in Antimicrobial Technologies for Medical Devices
Date:12/16/2010

HUNTERSVILLE, N.C., Dec. 16, 2010 /PRNewswire/ -- Hospital Acquired Infections (HAI's) are a serious health threat associated with over 100,000 deaths each year.  These secondary infections following surgery are a major contributor to increased healthcare costs; experts estimate they add in excess of $20 billion.

Microban International is leveraging its expertise in antimicrobial technologies for polymers to look for synergistic effects to help medical device manufacturers address bacterial contamination of medical devices commonly associated with HAI's.  "Our experience with a broad range of antimicrobial technologies and materials puts us in a unique position to be able to help medical device manufacturers get to market more quickly with more effective technologies," said Dr. Ivan Ong, VP of Research and Development for Microban International.

The company has recently made significant advances in the development of antimicrobial solutions for acetal (POM), a material commonly used in catheter tubing and connector components which can be a source of HAI's.  Acetals are prone to processing issues with many additives, causing chemical degradation and formaldehyde off-gassing in the final product.  A new antimicrobial solution has been developed that is compatible with acetal and causes no destabilization or formaldehyde generation.  Our findings show effective performance with greater than 4 log reductions against a wide variety of organisms using our standard, enhanced and human-serum based testing protocols.  "This new work is a significant step forward and will help medical device manufacturers to offer an antimicrobial solution that is more robust and provides more consistent antimicrobial performance," said Dr. Ong.  

Microban provides comprehensive development support and project management including engineering services, on-site microbiology, analytical efficacy testing and regulatory guidance.  For more information please visit http://www.microban.com/microban-medical.

Contact: Cady Warner, (704) 875-0806


'/>"/>
SOURCE Microban International
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dal-Tile Corp. Launches Two New Lines of Ceramic Tile with Microban(R) Silver Antimicrobial Technology
2. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
3. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
4. Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale dUrologie
5. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
6. International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery
7. Surface Logix Presents Positive Phase 1 Repeat-Dose Trial Data on SLx-4090 at The 16th International Symposium on Drugs Affecting Lipid Metabolism
8. Preclinical Data on Lead MEK Inhibitor, RDEA119, to be Presented at the 2007 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
9. Tumor Growth Inhibition and Pharmacokinetic Profile of NKTR-102 (PEG-Irinotecan) in Multiple Solid Tumors To Be Presented at Upcoming AACR-NCI-EORTC International Conference
10. Preimplantation Genetic Diagnosis International Society Refutes American Society of Reproductive Medicine Opinion - States Preimplantation Genetic Screening is Beneficial When Performed in Experienced Centers
11. Survival Data for Avicenas Amyotrophic Lateral Sclerosis Drug Candidate, AL-02, to be Presented at 18th International Symposium on ALS/MND
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2017)... , Aug. 3, 2017  Agragen, LLC, a ... active in the biopharmaceutical, nutraceutical, and aquacultural feed ... of its lead drug candidates, AGR131.  This drug ... cytokine from the blood of patients suffering from ... inflammatory bowel disease. ...
(Date:8/2/2017)... and BENTON, Ky. , Aug. 2, 2017   Marshall County ... its environmental services (ES) team to proactively reduce the risk of hospital-acquired infections (HAIs). The ... disinfection robot that uses UVC light energy to kill deadly pathogens such as C. ... Tru-D SmartUVC ... Tru-D in action in ...
(Date:8/1/2017)... 1, 2017   CerSci Therapeutics , a non-opioid ... , has received notice from the National Institute ... Health (NIH) that it has been awarded a Direct-to-Phase ... $650,000 in 2017 with an additional $1,000,000 to follow ... Drug application of their lead non-opioid drug candidate CT-044 ...
Breaking Medicine Technology:
(Date:8/16/2017)... ... August 16, 2017 , ... Summer days spent with ... family-owned supermarket, has put together suggestions for enjoying the season of sunshine. Add trying ... everyone in the family can join in on the fun. , Try Something ...
(Date:8/16/2017)... ... August 16, 2017 , ... Blue Health Intelligence (BHI) announced today ... Officer. Dr. Spiro brings over 30 years of clinical, healthcare IT, value-based care, and ... analytics solutions. , “I am thrilled to welcome Dr. Spiro to BHI,” said ...
(Date:8/16/2017)... , ... August 16, 2017 , ... Greenfield Advisors is ... in the U.S. for the second year in a row. The Inc. 5000 list ... three years. , “To be on the list once is a great accomplishment, but ...
(Date:8/16/2017)... ... 2017 , ... The Data Council, the leading provider of ... by Advantage Solutions. The Data Council’s IX-ONE platform is the Specialty, Natural ... suppliers, brokers, distributors and retailers. The Data Council will become a part of ...
(Date:8/16/2017)... ... August 16, 2017 , ... For the second year, the ... to educate the public on the impact of concussions. Brooke Mills, student and ... Concussion Awareness Day. , Brooke is working diligently is to raise awareness of ...
Breaking Medicine News(10 mins):